The ability of Klebsiella pneumoniae strains to resist the bactericidal activity of serum was quantitated. The K. pneumoniae strains tested included mutants lacking the capsular polysaccharide and mutants having a modified lipopolysaccharide structure. The last mutants were obtained as phage-resistant mutants, and their lipopolysaccharide was characterized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and chemical analysis. Serum-resistant mutants derived from phage-resistant mutants (lipopolysaccharide mutants) were also characterized. Resistance to the bactericidal activity of complement was mediated by the lipopolysaccharide, especially by the 0-antigen polysaccharide chains. The capsular polysaccharide seemed not to play any important role in resistance to serum bactericidal activity in this bacterium.
The complement system of homeothermic animals plays an important role in protection against bacterial infections. In nonimmune hosts, this primary defense is mediated largely through activation of the alternative complement pathway, whereas in immune hosts, both classical and alternative pathways participate. Complement can produce a direct bactericidal reaction between bacter-ia and phagocytic cells (9) .
Clearly, if an invading organism can resist the bactericidal activity of complement in nonimmune serum, it has a survival advantage and, hence, a pathogenic advantage. In the case of gram-negative pathogens of homeothermic animals, this virulence property is conferred by either normal lipopolysaccharide (LPS) or protein components of the outer membrane (OM) (4) . In immune animals, the binding of antibodies to cell surface components can overcome this resistance.
Klebsiellai paeiiioioiae biotypes are widely recognized as opportunistic pathogens acting as agents of bacteremias and respiratory and genitourinary infections, particularly in patients under stress (6) . Unlike other enterobacteria, K. pCnleuOniae contains a large capsular polysaccharide involved in colonization, adhesion, maintenance, and proliferation of this species on its host (24) . We isolated several K. pneunioniae bacteriophages whose receptor was the LPS (21, 26; J. M. Tomas and V. J. Benedi, manuscript in preparation). By using K. pnieil/noniiae C3 LPS mutants (isolated as phage-resistant mutants) and capsule mutants, we examined the role of the capsular polysaccharide and LPS in the survival of this strain in serum.
MATERIALS AND METHODS
Bacteria, bacteriophages, and media. The strains used are listed in Table 1 . Bacteriophages FC3-1, FC3-2, FC3-3, FC3-6, and FC3-9 were partially characterized previously (21) . The basal medium used for bacterial growth and phage propagation was Luria broth (LB) (16) or LB with 1.5% agar.
To prepare soft agar, we added 0.6% agar to LB.
Spontaneous mutants of K. pnelunzoniae C3 resistant to bacteriophage FC3-1 (a bacteriophage whose receptor is LPS) were previously described (26) . Spontaneous mutants * Corresponding author. of K. pnieiumoniiae C3 resistant to bacteriophages FC3-2, FC3-3, FC3-6, and FC3-9 were isolated by spreading a mixture containing 108 bacteria and 109 phage PFU on LB with 1.5% agar. After 36 h at 30°C, colonies of phageresistant mutants were picked. purified by streaking, and cross-streaked against the corresponding bacteriophage to confirm resistance. Resistance to the other bacteriophages was assayed by a spot test.
Bacterial survival in fresh nonimmune serum. The survival of logarithmic-phase bacteria in serum was measured. To 0.4 ml of fresh nonimmune rabbit serum was added 0.1 ml of a suspension in phosphate-buffered saline of bacteria in the logarithmic phase, adjusted by optical density to about 5 x 107 cells per ml. Viable counts were made at 30°C up to 3 h by the Miles-Misra method (15) after serial dilution in phosphate-buffered saline. Results are expressed as the percentage of inoculated bacteria that survived after a given time. Controls (bacteria in phosphate-buffered saline) showed no significant changes in viable counts over the incubation period. In some assays, the same serum previously heated at 56°C for 30 min or treated with 20 mM EDTA for 1 h at 37°C to destroy complement activity was used. Serum was usually used on the day of collection.
Serum-resistant mutants were obtained as survivors after treatment with fresh normal serum for 3 h. After 36 h at 30°C, colonies of serum-resistant mutants were picked, purified by streaking, and retested with fresh normal serum to confirm resistance.
Cell surface isolation and analyses. Cell envelopes were prepared by French pressure cell lysis at 16,000 Pa of whole cells or were disrupted by sonication, followed by the removal of unbroken cells at 10,000 x g for 10 min and by sedimentation of the membrane fraction at 100,000 x g for 2 h. Cytoplasmic membranes were solubilized twice with sodium lauryl sarcosinate (8) , and the OM fraction was sedimented twice at 100,000 x g for 2 h. OM proteins were solubilized in 1% deoxycholate-2 mM EDTA (20) . Membrane proteins were analyzed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis by a modification (1) of the Laemmli procedure (12) . Protein gels were routinely stained with Coomassie blue. Protein concentrations were determined by the Lowry procedure (13) with bovine serum albumin as the standard. (19) . For chemical analyses, purified LPS was hydrolyzed with 1 N HCl for 2 h at 100°C. Colorimetric analyses of the 2-keto-3-deoxyoctulosonic acid (KDO) and L-glycero-D-manno-heptose (heptose) contents of LPS were performed by the method of Osborn (19) . Organic phosphate was assayed by the method of Bartlett (2) . Monosaccharides were also analyzed as their alditol acetate derivatives by gas-liquid chromatography on a 3% SP-3840 column (Supelco Inc., Cras, Switzerland) at 225 and 180°C. Alditol acetate monosaccharides were obtained by a standard procedure (bulletin 774A, Supelco). Alditol acetate carbohydrate standards were either purchased from Supelco or prepared by us.
Purified LPS was further analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and silver stained by the method of Tsai and Frasch (28) . Purified LPS from Escherichia coli 055:B5 (smooth strain) for use as a standard was purchased from Difco Laboratories, Detroit, Mich.
Antisera. (i) Anti-LPS serum. Immune serum was obtained from adult New Zealand White rabbits previously injected with 50 p.g of purified LPS in Freund complete adjuvant, followed by two successive injections at 2-week intervals. After 2 weeks, the animals were bled, and serum was collected. Fresh normal serum was obtained from untreated animals.
(ii) Anti-capsule serum. Immune serum was obtained from adult New Zealand White rabbits by repeated immunization with whole Formalin-killed K. pneumoniae C3 cells (wild type) by the method of Edwards and Ewing (7). The serum was rendered capsular polysaccharide (K antigen) specific by extensive adsorption with the KT717 strain (01; Frield 204) as described by 0rskov and 0rskov (18) . Assay of antibody levels. Immune rabbit sera were tested with a solid-phase enzyme-linked immunosorbent assay (ELISA) for LPS (0.1 eug of antigen) and capsular polysaccharide (1 ,ug of antigen or 104 cells as antigen) independently. The developing antibody was a 1/50 dilution of affinity-purified goat anti-rabbit immunoglobulin G-alkaline phosphatase (27) .
RESULTS
Mutants resistant to bacteriophages FC3-1, FC3-2, FC3-3, FC3-6, and FC3-9 occurred spontaneously at a frequency of 1 x 10-6 to 5 x 10-6 and fell into a single class based on their phage sensitivity patterns (Table 2 ). They are represented by strains KT141, KT701, KT702, KT703, and KT707, respectively. The parent strain, K. pneumoniae C3, was sensitive to all of the five related phages (FC3-1, FC3-2, FC3-3, FC3-6, and FC3-9). Serum-resistant mutants (KT142, KT719, KT720, KT721, and KT723) were obtained as described in Materials and Methods from the serum-sensitive, phage-resistant mutants (KT141, KT701, KT702, KT703, and KT707, respectively). All of the serum-resistant mutants were sensitive to all of the five related phages ( No decrease was observed with strains C3 and KT717.
To determine whether differences in serum survival among strains were due to nutritional rather than bactericidal factors, we measured survival in serum heated or treated with 20 mM EDTA to destroy complement. These results (Table 3) showed that there were no significant this strain). There were also alterations in a number of bands, but there was no consistency from strain to strain. We also examined purified LPS from these strains by the method of Tsai and Frasch (28) (Fig. 3) . There was an apparently complete loss of 0 antigen in the purified LPS from the phage-resistant mutants, indicating that the 0 antigen was lost rather than altered in structure. Identical profiles were seen for strains C3 (wild type) and KT717 (nonencapsulated).
The chemical analyses of purified LPS from K. pneiumoniae C3 (wild type) and the phage-resistant mutants are shown in Table 4 shown). They also had LPS (with 0-antigen polysaccharide) identical to that of the wild-type strain (Fig. 3) , as determined by the method of Tsai and Frasch (28) .
Antibody assays. The ELISA for LPS revealed a 500-fold decrease (antibody titration) in the response against purified LPS from phage-resistant mutants in comparison with purified LPS from the wild type. No differences were observed between purified LPS from K. pneium1oniae C3 (wild type) and purified LPS from strain KT717 (nonencapsulated) or purified LPS from serum-resistant mutants (KT142, KT719, KT720, KT721, and KT723). The presence of capsular polysaccharide in these strains (Table 5 ) was detected by the ELISA as described in Materials and Methods. All the strains tested had capsular polysaccharide in similar amounts, except for strain KT717 (nonencapsulated).
DISCUSSION
K. pneilEnoniiae C3 has been serotyped as K66 for its K antigen and 01 for its LPS 0 antigen (I. 0rskov, personal communication). Bacteriophages FC3-1, FC3-2, FC3-3, FC3-6, and FC3-9 were previously characterized (21) , and we found that LPS alone is the receptor for all these K. pnfeiumoniiae phages (26; Tomis and Benedi, in preparation). Mutants resistant to these phages were isolated, and all of them had alterations in LPS structure. The common alteration in LPS composition was the lack of the 0 antigen in all of the phage-resistant mutants. This point was concluded from the LPS gels, the chemical composition of LPS from the wild type and from the mutants, and finally from the ELISA experiments with purified LPS.
The chemical composition of LPS from these mutants suggested three different chemotypes. The mutants selected for FC3-1 and FC3-6 phage resistance (KT141 and KT703), as described before (26) , appear to have xylose substituted in their remaining core oligosaccharides, and maybe this insertion of xylose stops the elongation of the LPS in these The changes observed in OM protein composition between the wild type and the phage-resistant mutants are possibly due to LPS differences. LPS and OM protein interactions have been well documented (1, 3, 23) . The most evident change in OM protein composition was observed in strain KT707, which lacks one of the major outer membrane proteins in K. pneilinoniae (36 kilodaltons), presumably one of the porins in this strain. KT707 is, to our knowledge, the first presumable porin mutant described in K. pneumoniae and may be very useful in transport studies, as in E. coli or Salmtionella tvphimnurium (17) . Furthermore, we have been able to find revertants from the phage-resistant mutants (which were serum sensitive) by selecting for resistance to serum bactericidal activity. The serum-resistant mutants (KT142, KT719, KT720, KT721, and KT723) derived from the phage-resistant mutants (KT141, KT701, KT702, KT703, and KT707, respectively) had LPS identical to that of the wild-type strain. This identity was concluded from the LPS gels, the phage sensitivity patterns, and the results obtained with the ELISA for purified LPS. They also had the same OM protein composition as the wild-type strain (data not shown).
That the ability of some pathogenic strains to resist complement killing clearly resides in their surface structure has already been described (22) . Indeed, it would appear that K. pneiumoniiae has a double barrier, the capsular polysaccharide and the LPS, able to prevent the access of membrane lytic complement to their membrane targets. This study has shown that the major contribution of LPS to resistance to serum bactericidal activity is mediated by the 0 antigen, as for nonencapsulated strains from other enterobacteria (14, 25 The role of capsular polysaccharide in resistance to serum bactericidal activity in K. pneumoniae seems to be null because strain KT717, with the same serotype for LPS (serotype 01) but without capsular polysaccharide, showed resistance very similar to that of the wild-type strain (encapsulated). Also, no changes in K antigen were observed in the phage-resistant mutants (LPS mutants). The complete LPS structure is obviously sufficient to confer resistance to complement killing, while capsular polysaccharide by itself clearly allows for the access of complement components to their targets. This study has defined an important role for LPS in the sensitivity of K. pneumoniae C3 (encapsulated strain) to serum. We also demonstrated that capsular polysaccharide does not play any important role in survival in serum. Furthermore, this study provides an interesting model for clarifying the contribution of LPS and capsular polysaccharide to different aspects of the pathogenicity of K. pneumoniae.
